Expanding role of bisphosphonates in the management of early breast cancer.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins School of Medicine, Baltimore, MD 21231-21000, USA. mhiggin9@jhmi.edu

Supplemental Content

Review The role of bisphosphonates in breast cancer. [J Natl Compr Canc Netw. 2003]
Review The role of bisphosphonates in breast cancer.
Theriault RL. J Natl Compr Canc Netw. 2003 Apr; 1(2):232-41.
Evolution of breast cancer management in Ireland: a decade of change. [BMC Surg. 2009]
Evolution of breast cancer management in Ireland: a decade of change.
Heneghan HM, Prichard RS, Devaney A, Sweeney KJ, Malone C, McLaughlin R, Kerin MJ. BMC Surg. 2009 Sep 18; 9:15. Epub 2009 Sep 18.
Review Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients. [Expert Rev Anticancer Ther. 2009]
Review Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
Kyrgidis A, Triaridis S, Vahtsevanos K, Antoniades K. Expert Rev Anticancer Ther. 2009 Aug; 9(8):1125-34.
Review Role of MRI in breast cancer management. [Cleve Clin J Med. 2009]
Review Role of MRI in breast cancer management.
Enriquez L, Listinsky J. Cleve Clin J Med. 2009 Sep; 76(9):525-32.
Review Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009. [Lancet Oncol. 2009]
Review Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
Wong NS, Anderson BO, Khoo KS, Ang PT, Yip CH, Lu YS, Voravud N, Shao ZM, Pritchard KI, Asian Oncology Summit. Lancet Oncol. 2009 Nov; 10(11):1077-85.

Expanding role of bisphosphonates in the management of early breast cancer.
Expanding role of bisphosphonates in the management of early breast cancer.
Expert Rev Anticancer Ther. 2009 Aug ;9(8):1051-4.

PubMed
How should we support pharmaceutical innovation?
How should we support pharmaceutical innovation?
Expert Rev Pharmacoecon Outcomes Res. 2009 Aug ;9(4):313-20.

PubMed
Guided care and the cost of complex healthcare: a preliminary report.
Guided care and the cost of complex healthcare: a preliminary report.
Am J Manag Care. 2009 Aug ;15(8):555-9.

PubMed
Low-energy femoral fractures associated with the long-term use of bisphosphonate...
Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.
Drug Saf. 2009 ;32(9):775-85. doi: 10.2165/00002018-200932090-00002.

PubMed
Mutant p53 gain of oncogenic function: in vivo evidence, mechanism of action and...
Mutant p53 gain of oncogenic function: in vivo evidence, mechanism of action and its clinical implications.
Fukuoka Igaku Zasshi. 2009 Jun ;100(6):217-28.

PubMed

Your browsing activity is empty.

Activity recording is turned off.